QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, April 29, 2009, 29(17):5666-5670; doi:10.1523/JNEUROSCI.0095-09.2009

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Xu, F. Articles by Van Nostrand, W. E. Search for Related Content PubMed PubMed Citation Articles by Xu, F. Articles by Van Nostrand, W. E.

 Previous Article  |  Next Article 

Brief Communications
AβPP/APLP2 Family of Kunitz Serine Proteinase Inhibitors Regulate Cerebral Thrombosis

Feng Xu,¹ Mary Lou Previti,¹ Marvin T. Nieman,² Judianne Davis,¹ Alvin H. Schmaier,² and William E. Van Nostrand¹

¹Department of Medicine, Stony Brook University, Stony Brook, New York 11794-8153, and ²Department of Medicine, Division of Hematology/Oncology, Case Western Reserve University, Cleveland, Ohio 44106

Correspondence should be addressed to Dr. William E. Van Nostrand, Department of Medicine, HSC T-15/083, Stony Brook University, Stony Brook, NY 11794-8153. Email: William.VanNostrand{at}stonybrook.edu

The amyloid β-protein precursor (AβPP) is best recognized as the precursor to the Aβ peptide that accumulates in the brains of patients with Alzheimer's disease, but less is known about its physiological functions. Isoforms of AβPP that contain a Kunitz-type serine proteinase inhibitor (KPI) domain are expressed in brain and, outside the CNS, in circulating blood platelets. Recently, we showed that KPI-containing forms of AβPP regulates cerebral thrombosis in vivo (Xu et al., 2005, 2007). Amyloid precursor like protein-2 (APLP2), a closely related homolog to AβPP, also possesses a highly conserved KPI domain. Virtually nothing is known of its function. Here, we show that APLP2 also regulates cerebral thrombosis risk. Recombinant purified KPI domains of AβPP and APLP2 both inhibit the plasma clotting in vitro. In a carotid artery thrombosis model, both AβPP^–/– and APLP2^–/– mice exhibit similar significantly shorter times to vessel occlusion compared with wild-type mice indicating a prothrombotic phenotype. Similarly, in an experimental model of intracerebral hemorrhage, both AβPP^–/– and APLP2^–/– mice produce significantly smaller hematomas with reduced brain hemoglobin content compared with wild-type mice. Together, these results indicate that AβPP and APLP2 share overlapping anticoagulant functions with regard to regulating thrombosis after cerebral vascular injury.

---

Received Jan. 8, 2009; revised March 31, 2009; accepted April 3, 2009.

Correspondence should be addressed to Dr. William E. Van Nostrand, Department of Medicine, HSC T-15/083, Stony Brook University, Stony Brook, NY 11794-8153. Email: William.VanNostrand{at}stonybrook.edu

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help